Literature DB >> 3825860

Ventricular arrhythmias in dilated cardiomyopathy: efficacy of amiodarone.

R Neri, L Mestroni, A Salvi, C Pandullo, F Camerini.   

Abstract

Sixty-five patients with dilated cardiomyopathy were studied by means of 24-hour ECG monitoring. Ventricular arrhythmias were present in 62 (95.4%), of whom 52 (80%) showed a complex form (multiform ventricular extrasystoles, pairs, and ventricular tachycardia). Forty-one patients, presenting with complex ventricular arrhythmias, received antiarrhythmic treatment with amiodarone (600 mg/day in the first week, 400 mg/day in the second week, and 200 to 400 mg/day chronically), and were then controlled with periodic 24-hour ambulatory monitoring. A significant reduction in the number of ventricular extrasystoles was seen in over 70% of patients during a 3-year period. There was also a significant decrease in the incidence of complex ventricular arrhythmias (particularly of ventricular tachycardia). Adverse effects were noted in 23 patients, but only four had to stop treatment. During the follow-up period, 19 patients died: 14 of heart failure, four of sudden death, and one of a noncardiac cause; all patients who died suddenly were not treated with amiodarone (p = 0.022). Complex ventricular arrhythmias are frequent in dilated cardiomyopathy and it is suggested that amiodarone is effective in short- and long-term control of these arrhythmias.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3825860     DOI: 10.1016/0002-8703(87)90711-3

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  8 in total

Review 1.  Ventricular arrhythmias in congestive heart failure: clinical significance and management.

Authors:  G R Khoshnevis; A Massumi
Journal:  Tex Heart Inst J       Date:  1999

Review 2.  Congestive heart failure. New frontiers.

Authors:  W W Parmley; K Chatterjee; G S Francis; B G Firth; R A Kloner
Journal:  West J Med       Date:  1991-04

3.  Cardiac electrophysiological actions of captopril: lack of direct antiarrhythmic effects.

Authors:  P D Hemsworth; R T Pallandi; T J Campbell
Journal:  Br J Pharmacol       Date:  1989-09       Impact factor: 8.739

Review 4.  Practical aspects of the use of amiodarone.

Authors:  P Puech
Journal:  Drugs       Date:  1991       Impact factor: 9.546

5.  Cardiac dysrhythmias in children with idiopathic dilated or hypertrophic cardiomyopathy.

Authors:  G Müller; H E Ulmer; K J Hagel; D Wolf
Journal:  Pediatr Cardiol       Date:  1995 Mar-Apr       Impact factor: 1.655

6.  Organic anion transporter oatp2-mediated interaction between digoxin and amiodarone in the rat liver.

Authors:  Takaaki Kodawara; Satohiro Masuda; Hiroko Wakasugi; Yuichi Uwai; Takahiro Futami; Hideyuki Saito; Takaaki Abe; Ken-ichi Inu
Journal:  Pharm Res       Date:  2002-06       Impact factor: 4.200

7.  Amiodarone in congestive heart failure: unravelling the GESICA and CHF-STAT differences.

Authors:  S C Hammill; D L Packer
Journal:  Heart       Date:  1996-01       Impact factor: 5.994

Review 8.  Amiodarone. An overview of its pharmacological properties, and review of its therapeutic use in cardiac arrhythmias.

Authors:  J Gill; R C Heel; A Fitton
Journal:  Drugs       Date:  1992-01       Impact factor: 9.546

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.